Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
delta 9 tetrahydrocannabinol/hampor
Länken sparas på Urklipp
10 resultat
Method for increasing cannabinol content in a lipid-based extract of cannabis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
This invention relates to ways of extracting and concentrating cannabinoids from plant substrates including hemp, and particularly ways of modifying ratios of various cannabinoids including trans-.DELTA.9-tetrahydrocannabinol (THC), Cannabinol (CBN) and Cannabidiol
Mixtures of cannabinoid compounds, and production and use thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national stage application (under 35 U.S.C. .sctn.371) of PCT/EP2014/063872, filed Jun. 30, 2014, which claims benefit of European Application No. 13182788.3, filed Sep. 3, 2013, the entire contents of which is fully incorporated herein
Orally consumable cannabinoid composition including lecithin
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resveratrol, and
Pharmaceutical composition comprising Cannabinoids
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and
Cannabinoid composition including a cytochrome p450 enzyme inhibitor
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol-(THC), Cannabidiol (CBD), and a cytochrome p450 enzyme inhibitor.
BACKGROUND OF THE INVENTION
Cannabinoids are a group of chemicals from Cannabis Sativa or Cannabis indica
Controlled Cannabis decarboxylation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FEDERAL SUPPORT STATEMENT
Not Applicable
SEQUENCE LISTING
Not Applicable
BACKGROUND OF THE INVENTION
Raw cannabis contains tetrahydrocannabinol carboxylic acid (THC-COOH); this substance is also referred to as THC acid, .DELTA.9-THC acid, THCA-A, or THCA.
The article that appears in the Journal of
Encapsulated cannabinoid formulations for transdermal delivery
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application includes material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent disclosure, as it appears in the Patent and Trademark Office files or records, but otherwise reserves all copyright rights
Encapsulated cannabinoid formulations for oral delivery
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application includes material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent disclosure, as it appears in the Patent and Trademark Office files or records, but otherwise reserves all copyright rights
Cannabinoid derivatives, methods of making, and use thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates generally to cannabinoid derivatives of delta-8-tetrahydrocannabinol (.DELTA..sup.8-THC), delta-9-tetrahydrocannabinol (.DELTA..sup.9-THC), and delta-6a-10a-tetrahydrocannabinol (.DELTA..sup.6a-10a-THC) that are active as either agonists or
Method for purifying cannabinoid compounds
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national stage application (under 35 U.S.C. .sctn. 371) of PCT/EP2016/060905, filed May 13, 2016, which is incorporated herein by reference in its entirety.
The present invention relates to methods for purifying one or two cannabinoid
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
